Reports

Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells

+ See all authors and affiliations

Science  25 Jun 1993:
Vol. 260, Issue 5116, pp. 1937-1942
DOI: 10.1126/science.8316834

Abstract

Oncogenic Ras proteins transform animal cells to a malignantphenotype only when modified by farnesyl residues attached tocysteines near their carboxyl termini. The farnesyltransferase thatcatalyzes this reaction recognizes tetrapeptides of the sequence CAAX,where C is cysteine, A is an aliphatic amino acid, and X is acarboxyl-terminal methionine or serine. Replacement of the twoaliphatic residues with a benzodiazepine-based mimic of a peptide turngenerated potent inhibitors of farnesyltransferase [50 percentinhibitory concentration (IC50) < 1 nM]. Unlike tetrapeptides, thebenzodiazepine peptidomimetics enter cells and block attachment offarnesyl to Ras, nuclear lamins, and several other proteins. Atmicromolar concentrations, these inhibitors restored a normal growthpattern to Ras-transformed cells. The benzodiazepine peptidomimeticsmay be useful in the design of treatments for tumors in whichoncogenic Ras proteins contribute to abnormal growth, such as that ofthe colon, lung, and pancreas.

Related Content